The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InReflecting a robust earnings season for major service providers, Thomson Reuters reported Q2 2026 revenue of $1.95 billion, fueled significantly by its strategic AI initiatives. This performance contributed to a 9% overall revenue increase, leading the company to upgrade its full-year growth outlook to 8%. Alongside these results, the company announced a joint venture with KKR to divest a 51% stake in its Global Print business for $500 million, while CVS Health simultaneously raised its full-year adjusted EPS guidance.
This positive momentum is further evidenced by Cencora, which reported a 5.1% revenue rise to $84.8 billion in its fiscal third quarter. Per market data, these figures highlight a trend of operational efficiency across the sector. The strategic shift toward high-growth segments and asset optimization, such as the TRI-KKR deal, underscores a broader corporate focus on maximizing shareholder value amid shifting market dynamics.
At the close of August 4, 2026, TRI stood at $109.15 while CVS was priced at $104.42. Investors are weighing these earnings beats against the broader economic backdrop, including the Fed's recent decision on July 29 to hold interest rates at 3.75%. Market participants should watch for further updates on the Global Print divestiture and the realization of AI-driven growth as key catalysts for price action.